Niva Bupa’s IPO to open on Thursday, price band fixed at Rs 70-Rs 74
Mumbai, Nov 4 (IANS) Niva Bupa Health Insurance Company on Monday said it has fixed the price band of Rs 70-Rs 74 per equity share of face value Rs 10 each for its maiden initial public offer (IPO). The IPO will open on Thursday for subscription and close on Monday. Investors can bid for a
Mumbai, Nov 4 (IANS) Niva Bupa Health Insurance Company on Monday said it has fixed the price band of Rs 70-Rs 74 per equity share of face value Rs 10 each for its maiden initial public offer (IPO).
The IPO will open on Thursday for subscription and close on Monday. Investors can bid for a minimum of 200 equity shares, and in multiples of 200 equity shares thereafter, said the health insurer.
The IPO is a mix of fresh issue of up to Rs 800 crore and an offer of sale (OFS) up to Rs 1,400 crore by Bupa Singapore Holdings Pte. Ltd., Fettle Tone LLP.
According to Niva Bupa, the proceeds from its fresh issuance will be utilised to the extent of Rs 1,500 crore for augmentation of capital base to maintain and strengthen solvency levels and general corporate purposes.
The offer is being made through the book-building process, wherein not less than 75 per cent of the net offer shall be available for allocation on a proportionate basis to qualified institutional buyers, not more than 15 per cent of the offer shall be available for allocation to non-institutional bidders, and not more than 10 per cent of the offer shall be available for allocation to retail individual bidders.
It is the country’s third largest and second fastest-growing standalone health insurance company (SAHI) based on overall health GDPI of Rs 54.94 billion in fiscal 2024, which grew at a CAGR of 41.37 per cent from fiscal 2022 to 2024, almost double of the industry’s average.
As of June 30, Niva Bupa insured 14.99 million lives. According to Redseer, Niva Bupa’s market share in the Indian SAHI market was 16.24 per cent for Fiscal 2024, based on retail health GDPI and for the five months ended August 31, stood at 17.29 per cent.
–IANS
na/
Losing 3-0 at home is a tough pill to swallow, and it calls for introspection, says Tendulkar
Next Articleଶ୍ରୀକ୍ଷେତ୍ର ପୁରୀରେ ଭକ୍ତି ଓ ନିଷ୍ଠାର ସହିତ ପାଳିତ ହୋଇଯାଇଛି ଯମ ଦ୍ଵିତୀୟା
Related Articles
New AI tool to revolutionise personalised cancer treatment

ସ୍ୱାସ୍ଥ୍ୟ ଓ ଜୀବନଶୈଳୀNew AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours. The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported. The AAnet AI tool, developed by the Sydney-based Garvan Institute
Covid-19 virus protein triggers immune attack on healthy cells: Study

ସ୍ୱାସ୍ଥ୍ୟ ଓ ଜୀବନଶୈଳୀCovid-19 virus protein triggers immune attack on healthy cells: Study
New Delhi: Amid a fresh wave of Covid-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, published in the journal Cell Reports, sheds light on how severe Covid complications may occur and suggests new ways to prevent immune-driven damage from
Global AI collaboration revolutionises personalised cancer treatment

ସ୍ୱାସ୍ଥ୍ୟ ଓ ଜୀବନଶୈଳୀGlobal AI collaboration revolutionises personalised cancer treatment
New Delhi: An international team of scientists has unveiled an artificial intelligence (AI) technique that securely analyses global cancer samples, paving the way for more personalised and privacy-protected cancer treatments. This innovative approach promises to accelerate personalised cancer treatment by enabling clinicians to match therapies to individual patients better, Xinhua news agency reported. The study
